1. Home
  2. EARN vs BWAY Comparison

EARN vs BWAY Comparison

Compare EARN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • BWAY
  • Stock Information
  • Founded
  • EARN 2012
  • BWAY 2003
  • Country
  • EARN United States
  • BWAY Israel
  • Employees
  • EARN N/A
  • BWAY N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • BWAY Medical/Dental Instruments
  • Sector
  • EARN Real Estate
  • BWAY Health Care
  • Exchange
  • EARN Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • EARN 187.6M
  • BWAY 177.4M
  • IPO Year
  • EARN 2013
  • BWAY 2019
  • Fundamental
  • Price
  • EARN $6.55
  • BWAY $10.66
  • Analyst Decision
  • EARN Hold
  • BWAY Strong Buy
  • Analyst Count
  • EARN 1
  • BWAY 3
  • Target Price
  • EARN N/A
  • BWAY $13.17
  • AVG Volume (30 Days)
  • EARN 639.2K
  • BWAY 57.5K
  • Earning Date
  • EARN 03-05-2025
  • BWAY 03-05-2025
  • Dividend Yield
  • EARN 14.53%
  • BWAY N/A
  • EPS Growth
  • EARN 277.67
  • BWAY N/A
  • EPS
  • EARN 1.02
  • BWAY 0.04
  • Revenue
  • EARN N/A
  • BWAY $38,631,000.00
  • Revenue This Year
  • EARN N/A
  • BWAY $388.82
  • Revenue Next Year
  • EARN $89.08
  • BWAY $18.70
  • P/E Ratio
  • EARN $6.46
  • BWAY $128.37
  • Revenue Growth
  • EARN N/A
  • BWAY 34.19
  • 52 Week Low
  • EARN $5.54
  • BWAY $4.61
  • 52 Week High
  • EARN $7.26
  • BWAY $11.25
  • Technical
  • Relative Strength Index (RSI)
  • EARN 46.05
  • BWAY 46.35
  • Support Level
  • EARN $6.44
  • BWAY $10.24
  • Resistance Level
  • EARN $6.65
  • BWAY $10.89
  • Average True Range (ATR)
  • EARN 0.13
  • BWAY 0.47
  • MACD
  • EARN 0.00
  • BWAY -0.04
  • Stochastic Oscillator
  • EARN 27.71
  • BWAY 10.34

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: